Australia markets closed

Silo Pharma, Inc. (SILO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.8801+0.0001 (+0.01%)
At close: 04:00PM EDT
1.8000 -0.08 (-4.26%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.35M
Enterprise value -2.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)80.31
Price/book (mrq)0.87
Enterprise value/revenue -32.16
Enterprise value/EBITDA 0.64

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-12.56%
S&P500 52-week change 321.08%
52-week high 33.0500
52-week low 31.2160
50-day moving average 31.7857
200-day moving average 31.7085

Share statistics

Avg vol (3-month) 3199.72k
Avg vol (10-day) 3599.54k
Shares outstanding 52.84M
Implied shares outstanding 62.84M
Float 82.54M
% held by insiders 16.35%
% held by institutions 15.65%
Shares short (15 Apr 2024) 4115.03k
Short ratio (15 Apr 2024) 40.68
Short % of float (15 Apr 2024) 44.31%
Short % of shares outstanding (15 Apr 2024) 44.05%
Shares short (prior month 15 Mar 2024) 450.72k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 315 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,347.41%

Management effectiveness

Return on assets (ttm)-24.86%
Return on equity (ttm)-43.97%

Income statement

Revenue (ttm)72.1k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-3.63M
Diluted EPS (ttm)-1.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.67M
Total cash per share (mrq)2.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.90
Book value per share (mrq)2.12

Cash flow statement

Operating cash flow (ttm)-3.22M
Levered free cash flow (ttm)-1.78M